Neuro Kinetics Tests for Traumatic Brain Injury

I-Portal NOTC
The I-Portal NOTC with Dynamic Off Vertical Axis Rotation and Goggles

Note: Investigational use only. Neuro Kinetics, Inc. does not have FDA clearance for mTBI or concussion indications.

Sports Medicine Concussion Research

An important high school athlete study is underway to refine and validate the I-Portal® test battery.  NKI is collecting base line data at the beginning of the sports season to compare post trauma for head injuries sustained during the season.

Traumatic Brain Injury

Traumatic Brain Injury (TBI) is the result of a blunt blow, jolt or blast overpressure to the head that disrupts brain function. The terms mild TBI (mTBI) and concussion are commonly used interchangeably, and have been linked with Post Traumatic Stress Disorder. The severity of head injuries range from a brief change in mental status or consciousness to extended unconsciousness and amnesia. In severe or multiple concussion cases, personality changes can occur with devastating results.

The Centers for Disease Control and Prevention estimates that at least 3.17 million Americans currently have a long-term or lifelong need for help to perform activities of daily living as a result of a TBI. Currently there is no accepted clinical method to objectively detect mTBI.

Neuro Kinetics  Neuro-Otologic Test Devices

NKI’s comprehensive I-Portal® neuro-otologic test devices are in wide use as a diagnostic tool for early disease detection by audiologists, ENT’s, neuro-otologists, neuro-ophthalmologist, and neurologists all over the world. The same multimodal tool is being used in research applications to detect mTBI and to monitor recovery from head trauma.

The I-Portal® tests are neuro-physiologic; measuring the eye’s response to various motion, oculomotor, and optokinetic stimuli. Early data shows I-Portal® tests can detect abnormalities resulting from head trauma even when structural imaging technologies show no damage. The test battery also suggests the data is significantly more objective than current neuro-psychological tests that rely partially on patient self diagnosis.

NKI is collaborating with military and sports medicine researchers to study new methods to objectively diagnose and monitor blast and blunt force head trauma.Our battery of tests can help examiners use and compare baseline data to post trauma data to make better return to play and return to duty decisions.

Neuro Kinetics Earns Approval from Health Canada to Sell Diagnostic Devices in Canada

Neuro Kinetics, Inc. (www.neuro-kinetics.com) is a fast-growing manufacturer of noninvasive medical test equipment used worldwide by audiologists, neurologists, neuro-otologists, ophthalmologists, otolaryngologists and other medical specialists in the detection and evaluation of neurological, otological and vestibular disorders. It has appointed leading Canadian medical device distributor AIM Instrumentation & Technologies (http://aimtechnologies.ca) as its sole representative in Canada.

Neuro Kinetics Earns Approval from Health Canada to Sell Diagnostic Devices in Canada

Company Appoints AIM Instrumentation as an Exclusive Canadian Distributor

PR Newswire

PITTSBURGH, Nov. 29, 2010

PITTSBURGH, Nov. 29, 2010 /PRNewswire/ — Neuro Kinetics, Inc. (NKI) (www.neuro-kinetics.com), manufacturers of noninvasive medical diagnostic equipment used worldwide to test for vestibular and neurological conditions, said today that it has been granted a license from Health Canada to sell three of its devices in Canada for clinical use.

The company previously had sold its equipment in Canada for research purposes only.

The three NKI devices now approved for clinical use by Health Canada’s Health Products and Food Branch (HPFB) are its I-Portal® NOTC (Neuro-Otologic Test Center) system, I-Portal® VNG (Video Nystagmography) system and I-Portal® VOG (Video Oculography) system, along with related accessories, software, training and support services.

NKI also said today that it has appointed leading Canadian medical device distributor AIM Instrumentation Ltd.(http://aimtechnologies.ca) as its sole representative in Canada. AIM has offices in Mississauga, Ontario, and Burnaby, British Columbia.

“We are delighted to be able to offer our technology and equipment to hospitals and clinicians across Canada,” said J. Howison Schroeder, NKI president and CEO. “AIM will be a great partner as we aggressively expand in the Canadian market. We expect strong results there.”  Added Vikki MacKay, AIM chief executive officer, “Neuro Kinetics’ products are world class and we are excited to bring them   to Canada. As the Canadian population ages, the need for advanced testing of balance and equilibrium conditions will be increasingly critical to fall prevention among the elderly and those with vestibular conditions. There is a real need in Canada for Neuro Kinetics’ expertise.”

MacKay noted that a number of hospital sales of NKI equipment in Canada have been pending, and with the regulatory approval can now be finalized.

ABOUT NEURO KINETICS, INC.

Neuro Kinetics, Inc. (www.neuro-kinetics.com) is a fast-growing manufacturer of noninvasive medical test equipment used worldwide by audiologists, neurologists, neuro-otologists, ophthalmologists, otolaryngologists and other medical specialists in the detection and evaluation of neurological, otological and vestibular disorders. The privately owned company, originating in the 1970s, pioneered the development of vestibular and neuro-otologic testing equipment, including the renowned Barany (rotational) chair. The company’s patented products include the I-Portal® NOTC (Neuro-Otologic Test Center) system, I-Portal® VNG (Video Nystagmography) system and I-Portal® VOG (Video Oculography) system, along with related accessories, software, training and support services. Users include doctors and researchers in universities and government facilities as well as specialists in fields such as audiology, neurology, neuro-otology, ophthalmology and otolaryngology.